Involvement of superoxide in excitotoxicity and DNA fragmentation in striatal vulnerability in mice after treatment with the mitochondrial toxin, 3-nitropropionic acid.
about
The possible mechanisms underlying the impairment of HIF-1α pathway signaling in hyperglycemia and the beneficial effects of certain therapiesOxidative Stress and the Use of Antioxidants in StrokeProtection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription.Fraternal twins: Swiprosin-1/EFhd2 and Swiprosin-2/EFhd1, two homologous EF-hand containing calcium binding adaptor proteins with distinct functions.DRAM1 regulates autophagy flux through lysosomesHistone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathwayThe protective effect of growth hormone on Cu/Zn superoxide dismutase-mutant motor neuronsSOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathyAre therapeutic effects of antiacne agents mediated by activation of FoxO1 and inhibition of mTORC1?Hyperglycemia-enhanced ischemic brain damage in mutant manganese SOD mice is associated with suppression of HIF-1alpha.Nitric oxide, oxidants, and protein tyrosine nitration.Mitochondria: a therapeutic target in neurodegenerationAntioxidant gene therapy against neuronal cell death.Do glial cells play an anti-oxidative role in Huntington's disease?Modulation of the ASK1-MKK3/6-p38/MAPK signalling pathway mediates sildenafil protection against chemical hypoxia caused by malonate.Uncoupling oxidative/energy metabolism with low sub chronic doses of 3-nitropropionic acid or iodoacetate in vivo produces striatal cell damage.Methylenedioxymethamphetamine inhibits mitochondrial complex I activity in mice: a possible mechanism underlying neurotoxicity.No spatial memory deficit exists in Kunming mice that recently recovered from motor defects following 3-nitropropionic acid intoxication.Depressive-like behavior in mice recently recovered from motor disorders after 3-nitropropionic acid intoxication.Acute and long-term response of dopamine nigrostriatal synapses to a single, low-dose episode of 3-nitropropionic acid-mediated chemical hypoxia.Decreased striatal dopamine release underlies increased expression of long-term synaptic potentiation at corticostriatal synapses 24 h after 3-nitropropionic-acid-induced chemical hypoxia.Age-dependent biphasic changes in ischemic sensitivity in the striatum of Huntington's disease R6/2 transgenic mice.Mitochondrial inhibitor models of Huntington's disease and Parkinson's disease induce zinc accumulation and are attenuated by inhibition of zinc neurotoxicity in vitro or in vivo.N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington's disease.Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms.Expression pattern of ataxia telangiectasia mutated (ATM), p53, Akt, and glycogen synthase kinase-3β in the striatum of rats treated with 3-nitropropionic acid.Long-lasting neuroprotective effect of sildenafil against 3,4-methylenedioxymethamphetamine- induced 5-hydroxytryptamine deficits in the rat brain.
P2860
Q24630072-495363DF-B043-4D27-9099-00638191572EQ26852796-5D02150C-3124-43CC-B49B-FBC67DEC83FBQ33551416-DB1D2C7B-EE03-4D8E-AEB1-13AFC8154C62Q34564550-C6CAF34E-B12D-40E8-80A6-91A66330DABCQ34733718-A686E71E-F16F-434B-B8D9-ACCBF03ABC12Q34923735-F7129491-0B84-439E-A58F-758F1FEAFB97Q35078519-A52DAA1E-7D54-465C-9422-D099B881A08BQ36360471-C198F61A-7D1D-498E-952E-F4F23C26921FQ37101662-A19D245E-6CD6-4FCF-8749-62F5EA4F569FQ37188664-C07400A8-0A9C-4CD2-9305-7A27C94FCB41Q37356224-F161A5C5-E3C0-4E95-AE0B-187C8ADF7E3AQ37466059-AE745597-472A-4E8B-AE28-6B788D27ACF4Q37647941-3E875466-2682-4329-8372-EE4AD66CA9AFQ38222578-3C268C46-3421-42D0-ADA1-A08DDFA40B7DQ39759995-183BC3ED-5FA4-4E76-9854-3879BAC21B4FQ40290500-9FC2AF96-D389-4DA0-B2E6-3D54EE2A2F2AQ40698227-2413C8B5-F276-4012-8694-94E2D10651A6Q41351634-3A4A87C2-3AEC-4291-AEC3-AA68C31F3B4DQ41351751-F9D92A4A-4F06-4548-85B4-6EA5F32FDF1DQ41841066-3E9BE961-7152-4E23-89B9-A3E9533B2ED7Q43073344-C3807D9E-D15B-40B9-A573-F5984B17A90DQ44405624-B408E8A5-14CE-431B-9A38-49A5BA33024FQ45288791-B57D3092-3316-4A31-B05E-706A67D2FFB9Q45306350-A59981FF-AF80-47B4-B958-0B154363ED59Q48158835-371012AD-3C07-4568-B98D-50E7FC62B311Q48567266-289F3928-E297-43F4-A6F0-D83F797D3ED2Q48878720-FBA1810C-5F96-4A49-869B-43240F1BA6A8
P2860
Involvement of superoxide in excitotoxicity and DNA fragmentation in striatal vulnerability in mice after treatment with the mitochondrial toxin, 3-nitropropionic acid.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Involvement of superoxide in e ...... toxin, 3-nitropropionic acid.
@en
Involvement of superoxide in e ...... toxin, 3-nitropropionic acid.
@nl
type
label
Involvement of superoxide in e ...... toxin, 3-nitropropionic acid.
@en
Involvement of superoxide in e ...... toxin, 3-nitropropionic acid.
@nl
prefLabel
Involvement of superoxide in e ...... toxin, 3-nitropropionic acid.
@en
Involvement of superoxide in e ...... toxin, 3-nitropropionic acid.
@nl
P2860
P1476
Involvement of superoxide in e ...... l toxin, 3-nitropropionic acid
@en
P2093
Pak H Chan
P2860
P304
P356
10.1097/00004647-200207000-00005
P50
P577
2002-07-01T00:00:00Z
P5875
P6179
1015244272